Seres Therapeutics (MCRB) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Seres Therapeutics (MCRB) over the last 11 years, with Q3 2025 value amounting to -$9.7 million.
- Seres Therapeutics' Other Gross PP&E Adjustments rose 4653.31% to -$9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.7 million, marking a year-over-year increase of 4653.31%. This contributed to the annual value of -$45.0 million for FY2024, which is 933.24% up from last year.
- Seres Therapeutics' Other Gross PP&E Adjustments amounted to -$9.7 million in Q3 2025, which was up 4653.31% from -$11.8 million recorded in Q2 2025.
- Seres Therapeutics' Other Gross PP&E Adjustments' 5-year high stood at $44.5 million during Q3 2021, with a 5-year trough of -$63.0 million in Q4 2022.
- Moreover, its 5-year median value for Other Gross PP&E Adjustments was -$14.0 million (2025), whereas its average is -$6.6 million.
- In the last 5 years, Seres Therapeutics' Other Gross PP&E Adjustments tumbled by 36304.43% in 2022 and then surged by 6261.37% in 2025.
- Over the past 5 years, Seres Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $24.0 million in 2021, then tumbled by 363.04% to -$63.0 million in 2022, then increased by 21.24% to -$49.6 million in 2023, then increased by 9.33% to -$45.0 million in 2024, then skyrocketed by 78.41% to -$9.7 million in 2025.
- Its Other Gross PP&E Adjustments was -$9.7 million in Q3 2025, compared to -$11.8 million in Q2 2025 and -$14.0 million in Q1 2025.